Kalii Chloridum + Natrii Chloridum Kabi

Potassium chloride and sodium chloride, the active ingredients in Kalii Chloridum + Natrii Chloridum Kabi, are electrolytes presented as an intravenous solution for electrolyte replacement therapy. They are used to correct potassium and sodium deficits in patients receiving parenteral nutrition, undergoing surgery, or experiencing acute fluid loss, and are commonly administered in intensive care units to maintain plasma electrolyte balance.

GNH USA supplies Kalii Chloridum + Natrii Chloridum Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

Kalii Chloridum + Natrii Chloridum Kabi is used to manage electrolyte disturbances, particularly potassium and sodium imbalances, in clinical settings. - Hypokalemia: restores low plasma potassium levels to the normal range. - Hyponatremia: replenishes sodium to correct serum sodium deficiency. - Peri‑operative fluid management: provides essential electrolytes during surgery. - Acute diarrhoea or vomiting: replaces losses of potassium and sodium. - Severe burns: supports electrolyte balance in extensive fluid loss.

Intravenous administration of potassium and sodium chloride can be associated with several adverse reactions.

Common Side Effects: - Infusion site irritation or pain. - Mild hyperkalemia leading to transient elevated potassium. - Mild hypernatremia causing thirst or mild edema. - Nausea or vomiting. - Phlebitis or vein inflammation.

Serious or Rare Side Effects: - Cardiac arrhythmias due to rapid potassium rise. - Severe hyperkalemia causing muscle weakness or paralysis. - Anaphylactic reaction to solution components. - Hyperosmolar coma from excessive sodium load. - Severe vein thrombosis or embolism.

Careful assessment and monitoring are essential when using this intravenous electrolyte solution. - Assess serum electrolytes before administration: verify potassium and sodium levels. - Adjust infusion rate: avoid rapid infusion exceeding recommended limits. - Monitor cardiac rhythm: watch for arrhythmias during potassium administration. - Avoid use in patients with severe renal impairment without dose adjustment. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Electrolyte solutions can interact with other medications, affecting safety and efficacy.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may increase risk of hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): can cause dangerous potassium accumulation. - Trimethoprim‑sulfamethoxazole: potentiates hyperkalemia.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce renal potassium excretion. - Other high‑sodium IV fluids: risk of hypernatremia if combined. - Digoxin: serum potassium levels influence digoxin toxicity.